Prot#: RD.06.SPR.18171: A Phase 3 randomized, double-blind, 12-week vehicle-controlled, parallel-group study assessing the efficacy and safety of CD5024 1 % cream versus vehicle cream in subjects with papulopustular rosacea, followed by a 40-week investig

Project: Research project

Project Details

Effective start/end date1/13/121/13/15


  • Premier Research International, LLC (RD.06.SPR.18171)
  • Galderma Laboratories, Inc (RD.06.SPR.18171)